Skip to main content
. 2001 May 1;98(10):5898–5903. doi: 10.1073/pnas.101116598

Figure 1.

Figure 1

(A) RPA of FGF-3 and GLp65 expression in the lungs after administration of RU486 at a dosage of 500 μg/kg for 1 week (+) on transgenic lines 1292, 1138H, and 1137. Bitransgenic littermates were administered placebo pellets as control (−). RPA of FGF-3 mRNA (B) and Western blot analysis of FGF-3 protein expression (C) in the lungs of mice from line 1138H after administration of placebo or RU486 at a dosage of 66, 130, and 200 μg/kg for 1 month are shown. Each lane represents an independent mRNA and protein from an individual mouse.